You have no items in your cart.
CFF Awards Up to $2M to Advance Eloxx’s Therapy ELX-02
Cystic Fibrosis News Today
The Cystic Fibrosis Foundation (CFF) is awarding Eloxx Pharmaceuticals up to $2 million in additional funding to support the clinical program of ELX-02, a potential therapy for cystic fibrosis (CF) caused ... Read more